Patents by Inventor Georg Achleitner
Georg Achleitner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9572818Abstract: Described are a sterile, ready-to-use, pharmaceutical oil-in water emulsion compositions for parenteral administration comprising: 0.015 to 1.2% wt/vol of progestogen; 0.5-30% wt/vol oil, wherein the oil comprises at least 85% wt/wt triglyceride; 0.0425-12.5% wt/vol phospholipid; 61.4-99.4% wt/vol aqueous medium; wherein the phospholipid is present in an amount of 6.8%-43% of the oil (wt/wt), and wherein the progestogen is present in an amount greater than or equal to 2.1 wt % of the oil. Also described are methods of making such compositions and method of using such compositions in therapeutic or prophylactic treatment, such as treatments comprising intravenous administration of the pharmaceutical composition.Type: GrantFiled: June 12, 2013Date of Patent: February 21, 2017Assignee: BESINS HEALTHCARE LUXEMBOURG SARLInventors: Georg Achleitner, Eva-Maria Hoiser, Laura Pickersgill
-
Publication number: 20150105471Abstract: The invention relates to an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration which contains paracetamol and has an electrical conductivity of not more than 200 ?S cm?1. The invention relates to an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration which contains paracetamol and has an electrical conductivity of not more than 200 ?S cm?1.Type: ApplicationFiled: May 20, 2014Publication date: April 16, 2015Applicant: Fresenius Kabi Deutschland GmbHInventors: David Dasberg, Georg Achleitner, Christiane Aichholzer
-
Publication number: 20140335133Abstract: Described are sterile, ready-to-use, pharmaceutical oil-in-water emulsion compositions for parenteral administration comprising: 0.015 to 0.5% wt/vol progesterone; 0.5 to 10% wt/vol oil, wherein the oil comprises at least 85% wt./wt. triglyceride; 0.0425 to 4.1% wt/vol phospholipid; 80-99.4% wt/vol aqueous medium; wherein the composition has an osmolality in the range of 200-1000 mOsm/kg. Also described are methods of making such compositions and method of using such compositions in therapeutic or prophylactic treatment, such as treatments comprising intravenous administration of the pharmaceutical composition.Type: ApplicationFiled: May 16, 2014Publication date: November 13, 2014Applicant: BESINS Healthcare Luxembourg SARLInventors: Georg Achleitner, Eva-Maria Hoiser, Laura Pickersgill
-
Patent number: 8765149Abstract: Described are sterile, ready-to-use, pharmaceutical oil-in-water emulsion compositions for parenteral administration comprising: 0.015 to 0.5% wt/vol progesterone; 0.5 to 10% wt/vol oil, wherein the oil comprises at least 85% wt./wt. triglyceride; 0.0425 to 4.1% wt/vol phospholipid; 80-99.4% wt/vol aqueous medium; wherein the composition has an osmolality in the range of 200-1000 mOsm/kg. Also described are methods of making such compositions and method of using such compositions in therapeutic or prophylactic treatment, such as treatments comprising intravenous administration of the pharmaceutical composition.Type: GrantFiled: April 25, 2011Date of Patent: July 1, 2014Assignee: Besins Healthcare Luxembourg SarlInventors: Georg Achleitner, Eva-Maria Hoiser, Laura Pickersgill
-
Patent number: 8741959Abstract: The invention relates to an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration which contains paracetamol and has an electrical conductivity of not more than 200 ?S cm?1.Type: GrantFiled: April 19, 2010Date of Patent: June 3, 2014Assignee: Fresenius Kabi Deutschland GmbHInventors: David Dasberg, Georg Achleitner, Christiane Aichholzer
-
Publication number: 20140147474Abstract: Described are a sterile, ready-to-use, pharmaceutical oil-in water emulsion compositions for parenteral administration comprising: 0.015 to 1.2% wt/vol of progestogen; 0.5-30% wt/vol oil, wherein the oil comprises at least 85% wt/wt triglyceride; 0.0425-12.5% wt/vol phospholipid; 61.4-99.4% wt/vol aqueous medium; wherein the phospholipid is present in an amount of 6.8%-43% of the oil (wt/wt), and wherein the progestogen is present in an amount greater than or equal to 2.1 wt % of the oil. Also described are methods of making such compositions and method of using such compositions in therapeutic or prophylactic treatment, such as treatments comprising intravenous administration of the pharmaceutical composition.Type: ApplicationFiled: June 12, 2013Publication date: May 29, 2014Applicant: BESINS Healthcare Luxembourg SARLInventors: Georg Achleitner, Eva-Maria Hoiser, Laura Pickersgill
-
Patent number: 8476252Abstract: Described are a sterile, ready-to-use, pharmaceutical oil-in water emulsion compositions for parenteral administration comprising: 0.015 to 1.2% wt/vol of progestogen; 0.5-30% wt/vol oil, wherein the oil comprises at least 85% wt/wt triglyceride; 0.0425-12.5% wt/vol phospholipid; 61.4-99.4% wt/vol aqueous medium; wherein the phospholipid is present in an amount of 6.8%-43% of the oil (wt/wt), and wherein the progestogen is present in an amount greater than or equal to 2.1 wt % of the oil. Also described are methods of making such compositions and method of using such compositions in therapeutic or prophylactic treatment, such as treatments comprising intravenous administration of the pharmaceutical composition.Type: GrantFiled: April 25, 2011Date of Patent: July 2, 2013Assignee: Besins Healthcare Luxembourg SARLInventors: Georg Achleitner, Eva-Maria Hoiser, Laura Pickersgill
-
Patent number: 8377876Abstract: The present invention relates to an amino acid solution for the parenteral nutrition of pediatric patients. The amino acid solution provides for an increased concentration of glutamine, tyrosine, cysteine and taurine, while the concentrations of phenylalanine and methionine is small. Glutamine and tyrosine are provided in the form of oligopeptides.Type: GrantFiled: March 5, 2007Date of Patent: February 19, 2013Assignee: Fresenius Kabi Deutschland GmbHInventors: Ortrud Brand, Thorsten Erbe, Georg Achleitner, Norbert Feichtinger
-
Publication number: 20120035267Abstract: The invention relates to an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration which contains paracetamol and has an electrical conductivity of not more than 200 ?S cm?1.Type: ApplicationFiled: April 19, 2010Publication date: February 9, 2012Applicant: Fresenius Kabi Deutschland GmbHInventors: David Dasberg, Georg Achleitner, Christiane Aichholzer
-
Publication number: 20110262495Abstract: Described are a sterile, ready-to-use, pharmaceutical oil-in water emulsion compositions for parenteral administration comprising: 0.015 to 1.2% wt/vol of progestogen; 0.5-30% wt/vol oil, wherein the oil comprises at least 85% wt/wt triglyceride; 0.0425-12.5% wt/vol phospholipid; 61.4-99.4% wt/vol aqueous medium; wherein the phospholipid is present in an amount of 6.8%-43% of the oil (wt/wt), and wherein the progestogen is present in an amount greater than or equal to 2.1 wt % of the oil. Also described are methods of making such compositions and method of using such compositions in therapeutic or prophylactic treatment, such as treatments comprising intravenous administration of the pharmaceutical composition.Type: ApplicationFiled: April 25, 2011Publication date: October 27, 2011Inventors: Georg Achleitner, Eva-Maria Hoiser, Laura Pickersgill
-
Publication number: 20110262494Abstract: Described are sterile, ready-to-use, pharmaceutical oil-in-water emulsion compositions for parenteral administration comprising: 0.015 to 0.5% wt/vol progesterone; 0.5 to 10% wt/vol oil, wherein the oil comprises at least 85% wt./wt. triglyceride; 0.0425 to 4.1% wt/vol phospholipid; 80-99.4% wt/vol aqueous medium; wherein the composition has an osmolality in the range of 200-1000 mOsm/kg. Also described are methods of making such compositions and method of using such compositions in therapeutic or prophylactic treatment, such as treatments comprising intravenous administration of the pharmaceutical composition.Type: ApplicationFiled: April 25, 2011Publication date: October 27, 2011Inventors: Georg Achleitner, Eva-Maria Hoiser, Laura Pickersgill
-
Publication number: 20090203626Abstract: The present invention relates to an amino acid solution for the parenteral nutrition of pediatric patients. The amino acid solution provides for an increased concentration of glutamine, tyrosine, cysteine and taurine, while the concentrations of phenylalanine and methionine is small. Glutamine and tyrosine are provided in the form of oligopeptides.Type: ApplicationFiled: March 5, 2007Publication date: August 13, 2009Inventors: Ortrud Brand, Thorsten Erbe, Georg Achleitner, Norbert Feichtinger
-
Publication number: 20090010701Abstract: A device for applying a gel-like substance, for instance a contact or ultrasonic gel, includes a gel container having an immersion tube departing from a docking area and extending into the gel-like substance; and an applicator for the gel-like substance mounted in the docking area, the applicator having a reservoir connected to an outlet nozzle as well as a pumping means for the gel-like substance. A tightly sealed connection can be established between the outlet nozzle of the applicator and the immersion tube for transporting the gel-like substances to the reservoir.Type: ApplicationFiled: January 25, 2007Publication date: January 8, 2009Inventors: Norbert Minarik, Georg Achleitner